肝移植对酒精相关性肝炎试验终点选择的影响
Suthat Liangpunsakul1, William B Krebs2, Allison J Kwong3
1Department of Medicine, Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Hepatology communications
|April 30, 2025
概括
早期的肝移植复杂化了与酒精相关的肝炎试验. 这项研究提出了统计方法和终点,以准确评估新疗法,并建议死亡率作为有效药物开发的主要分析.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 临床试验设计 临床试验设计
- 生物统计学 生物统计学
背景情况:
- 酒精相关性肝炎 (AH) 是一种严重的肝病,死亡率高 (90天~30%),没有经批准的药物治疗方法.
- 早期肝移植 (LT) 提供很高的存活率 (>90%),但由于其在研究中的过度代表性,使临床试验终点评估复杂化.
- 关于有效终点的未解决问题阻碍了对AH的有效治疗方法的开发.
研究的目的:
- 提出包括肝移植 (LT) 在酒精相关性肝炎 (AH) 临床试验中的方法方法.
- 解决效果大小,试验大小和统计方法对试验设计和解释在AH研究中的影响.
- 提供关于有效终点的建议和对 LT.复杂化治疗HA试验的统计分析.
主要方法:
- 使用了300名患者的AHFIRM试验 (2023年底完成) 的功率计算和数据.
- 评估了效果大小,试验大小和各种统计方法 (竞争风险分析,初级层分析,胜利率) 在试验设计中的作用.
- 评估了不同终点的效率,包括90天生存期和联合死亡或LT终点.
主要成果:
- 效应大小对于AH试验中的功率计算至关重要.
- 90天生存率是统计学上最有效的终点,而联合死亡或LT是最不有效的.
- 竞争风险分析,初级层分析和胜利率对于评估LT的作用有价值,并建议进行多重性调整.
结论:
- 早期采用肝移植 (LT) 复杂化了新的酒精相关性肝炎 (AH) 疗法的评估.
- 适当的统计方法和终点对于准确的功率计算和疗效评估至关重要.
- 死亡率应该是主要分析,并补充层次次的二次分析,以避免多重性问题,并确保可靠的试验解释.
相关概念视频
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...